Hormonal Manipulation in Breast Cancer
Author Information
Author(s): Boland G P, Mckeown A, Chan K C, Prasad R, Knox W F, Bundred N J
Primary Institution: University Hospital of South Manchester
Hypothesis
Does hormone manipulation affect cell proliferation and progesterone receptor expression in ductal carcinoma in situ (DCIS) based on oestrogen receptor status?
Conclusion
Hormonal manipulation significantly reduces cell proliferation in oestrogen receptor-positive DCIS but not in oestrogen receptor-negative DCIS.
Supporting Evidence
- Stopping HRT in OR-positive DCIS led to a significant reduction in cell proliferation.
- No change in cell proliferation was observed in OR-negative DCIS regardless of HRT status.
- PR expression decreased significantly in patients who stopped HRT.
Takeaway
This study shows that stopping hormone therapy can help slow down the growth of certain breast cancer cells, but it doesn't help all types.
Methodology
The study involved 108 women diagnosed with DCIS, comparing cell proliferation rates in those who stopped hormone replacement therapy (HRT) with those who continued or did not use HRT.
Potential Biases
Potential biases due to the nonrandomized design and reliance on retrospective data.
Limitations
The study is retrospective and has small subgroup sizes, which may limit the generalizability of the findings.
Participant Demographics
Median age of participants was around 56 years, with a mix of HRT users and non-users.
Statistical Information
P-Value
<0.01
Confidence Interval
95% CI of the mean difference: 2.07 to 7.71
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website